What is Asimov?
Asimov provides an end-to-end platform for genetic design by integrating state-of-the-art synthetic biology with computational tools. This platform empowers the design and manufacture of advanced therapies, focusing on biologics, viral vectors, and programmable medicines. The company offers a comprehensive suite including engineered host cells, an extensive library of genetic parts, and cloud-based design software.
Asimov supports partners through different collaboration models. They provide tools for in-house cell line development, including software, cells, and genes, or perform full cell line development services in their lab. Asimov continuously improves biological tools, data-driven models, and processes in the state-of-the-art Boston Lab, passing the benefits to its clients.
Features
- Host Cells: Engineered, highly characterized GMP host cells for therapeutic applications.
- Genetic Parts Library: Thousands of experimentally validated genetic parts to control cell biology.
- Design Software: Cloud-based software to design, simulate, and optimize genetic systems.
Use Cases
- Protein therapeutics production
- Gene therapy production
- Precise tuning and tissue-specific control of transgene expression in vivo.
